e-learning
resources
Berlin 2008
Monday, 06.10.2008
Impact of patient education on cost-effectiveness of treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Use of reliever medication and unscheduled medical care: who are this ashma patients?
R. Gerardo, L. Pires, M. Emiliano, L. Semedo, M. J. Valente (Lisboa, Portugal)
Source:
Annual Congress 2008 - Impact of patient education on cost-effectiveness of treatment
Session:
Impact of patient education on cost-effectiveness of treatment
Session type:
Thematic Poster Session
Number:
2664
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Gerardo, L. Pires, M. Emiliano, L. Semedo, M. J. Valente (Lisboa, Portugal). Use of reliever medication and unscheduled medical care: who are this ashma patients?. Eur Respir J 2008; 32: Suppl. 52, 2664
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Reason for non-compliance to inhaled medications among adult patients of asthma and COPD attending outpatient department in a tertiary care hospital
Source: International Congress 2016 – Asthma management in primary care
Year: 2016
Suboptimal asthma control among over-the-counter reliever purchasers in the community pharmacy.
Source: International Congress 2019 – Epidemiology of airway diseases in primary care
Year: 2019
Reducing inappropriate high dose ICS prescribing for COPD in primary care using respiratory integrated care virtual clinics
Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Year: 2015
Evaluation of the utilization patterns of anti-asthma medications at a university hospital
Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology II
Year: 2007
The differences of medication use between women with persistent asthma receiving care from specialty and non-specialty clinics
Source: Eur Respir J 2005; 26: Suppl. 49, 277s
Year: 2005
Prescribing patterns of inhaled corticosteroids in asthma amongst primary care physicians in Singapore
Source: Virtual Congress 2021 – Primary care organisation and epidemiology
Year: 2021
Oral corticosteroid prescription patterns in asthma care in Italy
Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Year: 2019
Prevalence of COPD in daily medical care: preoperative inspection/clinical survey/primary care clinics
Source: Eur Respir J 2006; 28: Suppl. 50, 741s
Year: 2006
Characteristics of COPD patients prescribed ICS managed in general practice vs. secondary care
Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19
Year: 2021
Inappropriate overuse of inhaled corticosteroids in patients with moderate COPD in UK primary care
Source: Annual Congress 2011 - Disease management in specific primary care populations
Year: 2011
COPD guides and inhaled corticosteroids. Is there an adequate use in primary care?
Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care
Year: 2016
Personalised prescribing for COPD patients: a primary care audit
Source: International Congress 2017 – Primary care diagnosis, assessment and management of COPD
Year: 2017
Organising your asthma clinic: how to optimise adherence to maintenance therapy
Source: Annual Congress 2012 - Improving adherence to maintenance medication in asthma: new tools for the clinician
Year: 2012
SABA and ICS use among mild asthma patients in UK primary care
Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Year: 2019
Antibiotic prescription in asthma exacerbations in the admitting and emergency (A&E) department
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011
Budesonide/formoterol maintenance and reliever therapy for asthma in general practice: is it cost-effective?
Source: Annual Congress 2008 - Diagnosing, monitoring and treating respiratory diseases in primary care
Year: 2008
REG endpoint validation: Do SABA prescribing records reliably reflect patient-reported reliever use?
Source: International Congress 2014 – Respiratory symptoms in primary care populations
Year: 2014
Late Breaking Abstract - Impact of maintenance and reliever therapy (MART)-focused asthma guideline on SABA prescriptions
Source: Virtual Congress 2021 – Highlights for primary care in 2021
Year: 2021
Impact of a new inhaler management policy on the hospitalised patient
Source: International Congress 2014 – From individual patient interactions to models of care: the nursing perspective
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept